OL
TAK icon

Optas LLC’s Takeda Pharmaceutical TAK Stock Holding History

Optas LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
+11,030
New +$183K 0.02% 470
2025
Q4 		– Sell
-11,254
Closed -$165K – 509
2025
Q3 		$165K Buy
+11,254
New +$167K 0.03% 379
2023
Q4 		– Sell
-10,158
Closed -$157K – 210
2023
Q3 		$157K Buy
+10,158
New +$157K 0.05% 172

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Optas LLC's TAK Position: Q2 2026 in Review

Optas LLC opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 11,030 shares worth $177K. The stake represents 0.02% of the portfolio and ranks #470 among its holdings. This is a return to the name: Optas LLC previously reported a position in TAK as recently as Q3 2025.

Optas LLC first reported a position in TAK in Q3 2023 and has held it in 3 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Optas LLC held 11,030 shares of Takeda Pharmaceutical worth $177K as of Q2 2026.
  • Takeda Pharmaceutical was a new Optas LLC position in Q2 2026.
  • Takeda Pharmaceutical made up 0.02% of Optas LLC's portfolio in Q2 2026, its #470 holding.
  • Optas LLC first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 3 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.